|
UCHL3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
4.92529999995828E-06 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
4.742100E-02 |
| Stage1-vs-Stage3 |
7.197600E-01 |
| Stage1-vs-Stage4 |
1.024730E-03 |
| Stage2-vs-Stage3 |
3.747700E-02 |
| Stage2-vs-Stage4 |
5.816500E-04 |
| Stage3-vs-Stage4 |
9.138900E-03 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
6.5674999993881E-08 |
| Normal-vs-Asian |
1.62447832963153E-12 |
| Caucasian-vs-AfricanAmerican |
7.163000E-01 |
| Caucasian-vs-Asian |
5.292600E-01 |
| AfricanAmerican-vs-Asian |
9.444000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
1.552780E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(81-100Yrs) |
5.464400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.301200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.954400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.652400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.753400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.241400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.125800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.330200E-01 |
| Classical-VS-Follicular |
1.9783000000384E-06 |
| Classical-VS-Other |
9.965800E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
2.0140999999918E-05 |
| Tall-VS-Other |
8.718600E-01 |
| Tall-VS-Normal |
1.62458935193399E-12 |
| Follicular-VS-Other |
1.455840E-01 |
| Follicular-VS-Normal |
2.95419999574165E-08 |
| Other-VS-Normal |
6.843200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
2.475100E-03 |
|
|
